drugset / Trial / NCT01942291

Short-term Effect of Extended-release Niacin on Endothelial Function.

NCT01942291

Phase 4 Completed 18 enrolled University of Campinas, Brazil
RandomizedCrossoverDouble-blindBasic science

Summary

Individuals with reduced plasma concentration of high-density lipoprotein (HDL) cholesterol are more susceptible to oxidative stress and often present reduced endothelial function, which has been mainly related to this susceptibility. Studies in animal and cell models have demonstrated that niacin activates both GPR-109A in leukocytes and heme oxygenase-1 (HO-1) pathway promoting strong anti-inflammatory and anti-oxidative effects. . In this context, the aim of this study was to investigate the short-term effect of niacin on endothelial function and verify the existence of interaction of PGD2 receptor antagonist, i.e. laropiprant (LRPT), in subjects with low HDL-cholesterol (HDL -C).

Timeline

Start
2012-03
Primary completion
2012-12
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule 1 g
Subject laropiprant Small molecule 20 mg